Royal Harbor Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Royal Harbor Partners, LLC

  • $188 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$207.02 - $241.31 $960,572 - $1.12 Million
-4,640 Closed
0 $0
Q4 2020

Jan 25, 2021
BUY
$207.01 - $276.09 $329,145 - $438,983
1,590 Added 52.13%
4,640 $1.1 Million
Q3 2020

Oct 08, 2020
BUY
$255.65 - $303.1 $779,732 - $924,455
3,050 New
3,050 $830,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Royal Harbor Partners, LLC Portfolio

Follow Royal Harbor Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Harbor Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email